Peritoneal carcinoma metastatic, also known as peritoneal carcinomatosis, is a serious condition where cancer spreads from other organs to the peritoneum—the thin membrane that lines the abdominal cavity and covers internal organs. Although this condition represents an advanced stage of cancer, specialized treatments combining surgery and chemotherapy are helping some patients live longer and maintain a better quality of life.

Understanding Peritoneal Carcinoma Metastatic

The peritoneum is a membrane that forms the inner lining of the abdominal cavity and wraps around the organs housed within it. This delicate tissue helps support the organs and contains blood vessels and nerves that keep them functioning properly. The space covered by the peritoneum inside the abdomen is called the peritoneal cavity.^[1]

When cancer spreads from its original location to other parts of the body, doctors call this metastasis. Peritoneal carcinoma metastatic happens when cancer cells travel from other organs and establish tumors on the peritoneum. This is different from cancers that start directly in the peritoneum itself, such as primary peritoneal cancer or peritoneal mesothelioma, which are very rare.^[1]

When cancer spreads to the peritoneum from other organs, it is considered advanced disease and typically indicates Stage IV cancer in most cases. Although any type of cancer can potentially spread to the peritoneum, the condition most commonly develops from cancers that originate in the abdomen or pelvis.^[1][2]

Epidemiology and Who Is Affected

Peritoneal carcinoma metastatic is not a common condition, with approximately 7 cases occurring per million people. However, it represents a significant cause of advanced abdominal malignancy worldwide. The exact incidence rates are challenging to define because the condition originates from multiple different cancer types rather than being a single distinct disease.^[4]

Women may face a higher risk of developing peritoneal carcinoma metastatic, particularly those around the ages of 56 to 62 years. This increased risk among women is largely because ovarian cancer, which is one of the most common sources of peritoneal metastases, affects only women. However, both men and women can develop this condition when it originates from other abdominal cancers.^[4]

The disease can be divided into different categories based on where the cancer originally started. These categories include peritoneal origins, gastrointestinal origins such as appendiceal and colorectal cancers, and ovarian origins. Among these, appendiceal mucinous neoplasms are notable contributors to peritoneal spread.^[4]

Causes and How Cancer Spreads to the Peritoneum

Peritoneal carcinoma metastatic forms when cancer cells from a tumor in one part of the body travel to the peritoneum and begin growing there. Usually, the cancer begins in a nearby organ within the abdomen, such as the ovaries, colon, or stomach. The cancer cells can spread directly across the abdominal cavity because they are in close physical proximity to the peritoneum.^[2]

In approximately 10% of people with peritoneal carcinoma metastatic, the cancer starts in organs located outside the abdominal cavity. When this happens, cancer cells use the bloodstream or the lymphatic system—a network of vessels that carries fluid throughout the body—to reach the peritoneum. Once cancer cells arrive at the peritoneum, they can implant themselves and form new tumors.^[2][10]

According to research, peritoneal metastases tend to develop in specific areas where the peritoneal fluid naturally slows down or pools. These locations include the pelvic peritoneal reflections, the right and left paracolic gutters (the spaces along the sides of the colon), the upper part of the sigmoid mesocolon, the area around the end of the small intestine, and the right subdiaphragmatic space beneath the diaphragm.^[5]

Risk Factors

Patients who have been diagnosed with certain types of cancer face an elevated risk of developing peritoneal carcinoma metastatic. The primary cancers most likely to spread to the peritoneum include ovarian cancer, which is the most common source, followed by colon cancer, stomach cancer, pancreatic cancer, appendix cancer, and rectal cancer.^[1][2]

For women specifically, risk factors include age, with women in their late 50s and early 60s being more vulnerable. Having a family history of ovarian or peritoneal cancer increases risk, as do genetic mutations known as BRCA1 and BRCA2. These are inherited gene changes that significantly raise the likelihood of developing certain cancers. Women who have used hormone replacement therapy after menopause, those with obesity or excess weight, and those with greater height also face increased risk. Additionally, having endometriosis—a condition where tissue similar to the uterine lining grows outside the uterus—may contribute to higher risk.^[18]

People with cancers of abdominal origin, including gastric (stomach), ovarian, colorectal, appendix, and pancreatic cancers, should be aware of their elevated risk. Less commonly, other types of cancer can also spread to the peritoneum. Anyone who believes they may be at risk should discuss this concern with their doctor.^[1]

Symptoms and How They Affect Patients

Many people with peritoneal carcinoma metastatic do not experience noticeable symptoms in the early stages of the disease. Symptoms typically only become apparent when the cancer affects a large portion of the peritoneum and begins interfering with nearby organs such as the intestines, bladder, and stomach.^[2][3]

The most common symptom of peritoneal carcinoma metastatic is abdominal swelling or bloating. This swelling is caused by fluid buildup in the abdomen, a condition known as ascites. When fluid accumulates, a person may feel that they are gaining weight in the belly area despite maintaining their usual diet and exercise habits. Women who have gone through menopause might notice that their abdomen appears distended in a way that resembles pregnancy.^[3][10]

Along with swelling, many patients experience abdominal pain or discomfort. This pain is often described as a vague cramping sensation or pressure-like feeling rather than sharp, localized pain. The discomfort may come and go or persist for extended periods. Some people also develop lower back pain as the condition progresses.^[2][3]

Changes in appetite are common with this condition. Patients frequently report a loss of appetite or feeling full very quickly, even after eating only small amounts of food. This early satiety can lead to unintended weight loss despite the abdominal swelling from fluid retention. Conversely, some patients may experience unexplained weight gain due to the accumulating fluid.^[2][3]

Digestive problems often develop as the cancer affects the gastrointestinal system. Nausea and vomiting are common, particularly when tumor deposits press against the intestines or stomach. Changes in bowel habits may occur, including constipation or, less commonly, diarrhea. These bowel changes happen because the tumors can partially obstruct the intestines or interfere with their normal movement.^[3][10]

Fatigue is another frequent symptom that can significantly impact daily life. Patients often feel extremely tired even after resting. This exhaustion may result from the body’s immune response to cancer, poor nutrition due to eating difficulties, or the overall burden of advanced disease.^[2][3]

As the disease progresses, complications can become more severe. Some patients develop bowel obstructions, where the intestines become partially or completely blocked. This can cause intense abdominal pain, inability to pass stool or gas, and severe vomiting. Urinary tract obstruction may also occur if tumors block the ureters—the tubes that carry urine from the kidneys to the bladder. In some cases, shortness of breath develops when fluid accumulation pushes up against the diaphragm, making it difficult to take deep breaths.^[6][10]

Prevention

While it is not always possible to prevent cancer from spreading to the peritoneum, certain measures may help reduce risk or detect problems early. For people who have already been diagnosed with cancers that commonly spread to the peritoneum, close monitoring and appropriate treatment of the primary cancer are essential first steps.^[18]

Maintaining overall health through lifestyle choices may contribute to reducing cancer risk in general, although specific prevention strategies for peritoneal metastases are limited. Recommended health-promoting habits include avoiding smoking or quitting if currently smoking, engaging in regular physical activity, and following a healthy diet rich in fruits and vegetables while limiting processed foods, saturated fats, and added sugars.^[18]

For individuals with genetic risk factors, such as BRCA1 or BRCA2 mutations, genetic counseling and testing can provide valuable information. Understanding genetic risk allows for more intensive screening programs and, in some cases, preventive surgical procedures. Women at very high risk of ovarian cancer, which frequently spreads to the peritoneum, may discuss preventive options with their doctors.^[18]

According to research, in some clinical situations involving appendiceal and colorectal cancers, certain clinical or histopathologic features may indicate that second-look surgery combined with perioperative chemotherapy should be considered. This preventive approach aims to treat microscopic cancer cells before they develop into established peritoneal metastases.^[17]

Regular screening for cancers that may spread to the peritoneum is important for early detection and treatment. For example, colonoscopy screening for colorectal cancer, pelvic examinations and imaging for ovarian cancer in high-risk women, and appropriate follow-up for appendiceal tumors can all contribute to catching problems before they progress to peritoneal involvement.^[18]

Pathophysiology: Changes in the Body

Understanding how peritoneal carcinoma metastatic affects the body requires knowledge of normal peritoneal function and what happens when cancer disrupts it. The peritoneum normally produces a small amount of fluid that lubricates the abdominal organs, allowing them to move smoothly against each other during breathing and digestion. This peritoneal fluid also circulates through the abdominal cavity in predictable patterns.^[5]

When cancer cells reach the peritoneum, they can implant themselves and begin forming tumors. These malignant implants or nodules become disseminated along the peritoneal surfaces. The presence of cancer disrupts the normal balance of fluid production and absorption in the abdomen, often leading to excessive fluid accumulation. This is why ascites becomes such a prominent feature of the condition.^[4]

The cancer deposits on the peritoneum can range in appearance and composition. Some present as distinct nodular implants scattered across the peritoneal surface, while others involve infiltration of the peritoneal fatty tissue. In cases originating from mucinous tumors, particularly appendiceal cancers, large volumes of thick, jelly-like mucin can accumulate in the abdominal cavity, a condition sometimes called pseudomyxoma peritonei.^[4][5]

As tumors grow on the peritoneum, they can directly invade nearby organs or compress them. When tumor deposits affect the intestines, they may cause partial or complete obstruction by narrowing the intestinal passage or interfering with the coordinated muscle contractions that move food through the digestive tract. This mechanical interference explains many of the gastrointestinal symptoms patients experience.^[4]

The presence of widespread cancer in the peritoneum triggers inflammatory responses in the body. This inflammation, combined with the cancer’s metabolic demands, contributes to constitutional symptoms such as fatigue and weight loss. The body’s immune system attempts to fight the cancer, but this response can also cause collateral damage to normal tissues and contribute to the overall decline in function.^[9]

Peritoneal carcinoma metastatic is often multifocal, meaning it affects multiple areas simultaneously rather than forming a single tumor. This widespread distribution makes the condition particularly challenging because it affects not only the peritoneum but can potentially involve numerous structures within the abdominal cavity. The progressive nature of the disease means that without treatment, the cancer continues to grow and spread, leading to increasing complications and declining organ function.^[4]